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PHeart Failure
Exercise Oscillatory Ventilation May Predict
Sudden Cardiac Death in Heart Failure Patients
Marco Guazzi, MD, PHD, FACC,* Rosa Raimondo, MD,† Marco Vicenzi, MD,* Ross Arena, PHD,§
Chiara Proserpio, MD,‡ Simona Sarzi Braga, MD,† Roberto Pedretti, MD†
Milano, Tradate, and Varese, Italy; and Richmond, Virginia
Objectives The purpose of this study was to test the ability of cardiopulmonary exercise testing (CPET)-derived variables as sud-
den cardiac death (SCD) predictors.
Background The CPET variables, such as peak oxygen uptake (VO2), ventilatory requirement to carbon dioxide (CO2) produc-
tion (VE/VCO2) slope, and exercise oscillatory breathing (EOB), are strong predictors of overall mortality in
chronic heart failure (CHF) patients. Even though up to 50% of CHF patients die from SCD, it is unknown whether
any of these variables predicts SCD.
Methods One hundred fifty-six CHF patients (mean age: 60.9  9.4 years; mean ejection fraction: 34.9  10.6%) under-
went CPET. Subjects were tracked for sudden versus pump-failure cardiac mortality over 27.8  25.2 months.
Results Seventeen patients died from SCD, and 17 died from cardiac pump failure. Survivors showed significantly higher
peak VO2 (16.8  4.5 ml·kg
1·min1) and lower VE/VCO2 slope (32.8  6.4) and prevalence of EOB (20.3%),
compared with subjects who experienced arrhythmic (13.5  3.2 ml·kg1·min1; 41.5  11.4; 100%) or nonar-
rhythmic (14.1  4.7 ml·kg1·min1; 38.1  7.3; 47.1%) deaths (p  0.05). At Cox regression analysis, all vari-
ables were significant univariate predictors of both sudden and pump failure death (p  0.01). Multivariate anal-
ysis, including left ventricular (LV) ejection fraction, LV end systolic volume, and LV mass selected EOB, was the
strongest predictor of both overall mortality (chi-square: 38.7, p  0.001) and SCD (chi-square: 44.7, p 
0.001), whereas VE/VCO2 slope was the strongest ventilatory predictor of pump failure death (chi-square: 11.8,
p  0.001).
Conclusions Exercise oscillatory breathing is an independent predictor of SCD in patients with CHF and might help as an ad-
ditional marker for prioritization of antiarrhythmic strategies. (J Am Coll Cardiol 2007;50:299–308) © 2007 by
the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.03.042d
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vp to 50% of total mortality in patients with chronic heart
ailure (CHF) is attributable to sudden cardiac death
SCD). Selection of those who exhibit an increased risk of
CD and prioritization to treatments with effective impact
n mortality, such as implantable cardioverter-defibrillator
ICD) therapy, are highly advocated (1). Nonetheless, the
ndiscriminate use of ICDs is an economically costly under-
aking (1,2), and patients with negligible risk of SCD might
e exposed to the potential risks of invasive procedures
ithout benefit. In this subset of patients, the ICD will not
mprove overall mortality but has the potential to hasten
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onzino Foundation and a grant from the University of Milano (FIRST grant 2005)
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007, accepted March 5, 2007.eath and negatively impact quality of life (2). Therefore,
ubcategorizing of risk stratification with regard to sudden
nd pump failure death is of essential impact for clinical
ecision-making, and identification of markers predictive of
isk of death for a specific cause remains a relevant challenge
1,3). A considerable number of cardiopulmonary exercise
esting (CPET)-derived variables provide basic prognostic
nformation in patients with CHF of different severity (4–6).
mong others, oxygen consumption at peak exercise (peak
O2) (7,8) and abnormalities in exercise ventilation such as
n excessive ventilatory requirement/carbon dioxide produc-
ion rate (VE/VCO2) and peculiar patterns of exercise
scillatory breathing (EOB) have gained a primary role as
eference markers of total mortality in CHF patients with
ither left ventricular (LV) systolic (9–16) or diastolic
ysfunction origin (17). Despite this evidence, no study has,
o the best of our knowledge, been focusing on the potential
alidity of these variables in the prediction of SCD. This
eems to be an interesting issue mainly concerning the
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nisms that sustain exercise intol-
erance in CHF patients and the
neural instability—such as an
impaired central and peripheral
chemoreflex control of ventila-
tion—that underlies abnormali-
ties in ventilation (18,19). Ac-
cordingly, the aim of the present
study was to test whether and
which exercise CPET-derived
variables predict an increased
burden of risk for SCD.
Methods
Subject characteristics. One hun-
dred and fifty-six patients with
compensated CHF were enrolled
in this study. All were optimally
managed from a pharmacologic
standpoint before initiation of
the study.
Echocardiography. Standard
-mode and 2-dimensional echocardiography and Doppler
lood flow measurements were performed in agreement
ith the American Society of Echocardiography Guidelines
20). Septal and posterior LV wall thickness was obtained
rom the parasternal long-axis view. The LV end-systolic and
diastolic volumes were obtained from 2-dimensional apical
mages. The LV ejection fraction (EF) was calculated accord-
ng to Simpson’s method from 2-dimensional apical images.
aseline Characteristics
Table 1 Baseline Characteristics
All Patients (n  156)
Age, yrs 60.9 9.4
Gender, M/F 125/31
Etiology, ischemic/nonischemic 98/58
NYHA functional class, I/II/III/IV 38/73/38/7
Mean SD 2.1 0.81
Echocardiography
LVEF, % 34.5 10.6
LVESV, ml 107 63
LVEDV, ml 184 64
LV mass, g 225 80
E/A ratio 1.9 0.5
IVRT, ms 103 34
DT, ms 220 70
Therapy distribution
ACE inhibitor 76%
Anti-aldosterone 39%
Beta-blocker 46%
Survivors significantly more than sudden cardiac death (SCD) and pump failure groups (p 0.05)
ore than survivors and pump failure death group (p  0.05).
Abbreviations
and Acronyms
CI  confidence interval
CPET  cardiopulmonary
exercise test
EF  ejection fraction
EOB  exercise oscillatory
breathing
ICD  implantable
cardioverter-defibrillator
LV  left
ventricle/ventricular
RER  respiratory
exchange ratio
ROC  receiver-operating
characteristic
SCD  sudden cardiac
death
VCO2  carbon dioxide
production
VE  ventilation
VO2  oxygen uptakeACE  angiotensin-converting enzyme; DT  deceleration time; E/A  early to late ventricular filling; E
elaxation time; LV  left ventricular; NYHA  New York Heart Association.he LV mass was calculated according to the formula pro-
osed by Devereux et al. (21).
Pulsed wave Doppler echocardiography was used to
ssess: mitral peak early (E) and late (A) wave flow velocity
nd E wave deceleration time. Isovolumic relaxation time
IVRT) was also determined.
PET. Each patient performed a supervised, standard,
rogressively increasing (personalized ramp protocol) work
ate CPET to maximum tolerance on an electromagneti-
ally braked cycle ergometer at baseline and during the
ollow-up assessments. The aim was to achieve peak exercise
n approximately 10 min. If test duration was 12 min or
8 min, the test was repeated the next day with the work
ate increase adjusted as needed. Ventilatory expired gas
nalysis was obtained with a metabolic cart (Medgraphics
PET-D, Minneapolis, Minnesota). The oxygen and car-
on dioxide sensors were calibrated before each test with
ases with known oxygen, nitrogen, and carbon dioxide
oncentrations. The flow sensor was also calibrated before
ach test with a 3-l syringe. Monitoring consisted of
ontinuous 12-lead electrocardiography, manual blood pres-
ure measurements every stage, heart rate recordings every
tage via the electrocardiogram, and rating of perceived
xertion (Borg 15 grade scale) each stage. Test termination
riteria consisted of patient request, ventricular tachycardia,
2 mm of horizontal or downsloping ST-segment depres-
ion, or a drop in systolic blood pressure 20 mm Hg
uring exercise. A qualified exercise physiologist with phy-
ician supervision conducted each tests.
The VO2 (ml·kg
1 ·min1), VCO2 (l ·min
1), and VE
l·min1) were collected throughout the exercise test. Peak
vors (n  122)
Nonsurvivors (n  34)
SCD (n  17) Pump Failure (n  17)
0.4 9.9 63.2 7.2 62.3 7.6
95/27 17/0 13/4
76/46 9/8 13/4
7/61/23/1 0/5/7/5 1/7/8/1
1.9 0.72* 3.0 0.79 2.5 0.72
6.1 9.7 25.2 6.3† 34.9 10.6
95 64 118 50‡ 105 48
45 75* 195 60 190 64
15 70 260 60‡ 235 70
1.7 0.5* 2.2 0.35 2.3 0.32
04 30 92 30† 100 25
46 73 150 70† 165 78
79% 65% 70%
32%* 59% 65%
46% 34%† 59%
group significantly less than survivors and pump failure group (p 0.05). ‡SCD group significantlySurvi
6
3
3
1
2
1
2
. †SCDDV  end-diastolic volume; EF  ejection fraction; ESV  end-systolic volume; IVRT  isovolumic
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July 24, 2007:299–308 Exercise Periodic Breathing and Sudden DeathO2 was expressed as the highest 30-s average value
btained during the last stage of the exercise test. Peak
espiratory exchange ratio (RER) was the highest 30-s
veraged value during the last stage of the exercise test.
en-second averaged VE and VCO2 data, from the initia-
ion of exercise to peak, were input into spreadsheet
oftware (Microsoft Excel, Microsoft Corp., Bellevue,
ashington) to calculate the VE/VCO2 slope via least
quares linear regression (y  mx  b, m  slope).
OB definition. The EOB was assessed with the criteria
reviously reported by Leite et al. (15). Specifically, EOB
as defined according to the following criteria: 1) 3 or more
egular oscillatory fluctuations in VE; 2) minimal average
mplitude of ventilatory oscillation of 5 l (peak value  the
verage of 2 in-between consecutive nadirs); and 3) a regular
scillation as defined by an SD of 3 consecutive cycle
engths (time between 2 consecutive nadirs) within 20% of
he average.
ode of death. Subjects were followed for cardiac-related
ortality via medical chart review. Cause of cardiac-related
eath was also determined, and death was classified as
udden death, pump failure, or resulting from other causes.
ll deaths were reviewed, and probable cause was estab-
ished by a committee of 3 physicians after a review of
ospital records, autopsy findings, death certificates, and
nterviews with family members. Sudden death was defined
s witnessed cardiac arrest or death within 1 h after the
nset of acute symptoms or unexpected, unwitnessed death
i.e., during sleep) in a patient known to have been well
ithin the previous 24 h (22). Deaths resulting from CHF
eterioration with progression of congestive symptoms were
lassified as pump failure. Patients in whom mortality was of
noncardiac etiology were treated as censored cases.
tatistical analysis. One way analysis of variance was used
o compare continuous variables amongst survivors, the SD
roup, and the pump failure death group. Tukey’s test for
ultiple comparison was used when a significant difference
as detected. Chi-square analysis was used to assess differ-
nces in categorical variables amongst the 3 groups.
eceiver-operating characteristic (ROC) curves were con-
PET Data
Table 2 CPET Data
All Patients (n  156)
Peak VO2, ml·min
1·kg1 16.6 4.6
VE/VCO2 slope 34.5 7.9
Peak RER 1.01 0.13
Peak PetCO2, mm Hg 33.2 5.4
EOB, % 33
VE/VCO2 slope 37.0, % 34
Peak VO2 14.4 ml·min
1·kg1, % 39
Survivors significantly more than sudden cardiac death (SCD) and pump failure death group (p
ignificantly less than SCD group (p  0.05). §SCD group significantly more than pump failure de
CPET  cardiopulmonary exercise test; EOB  exercise oscillatory breathing; PetCO2  end-tida
xygen uptake.tructed for peak VO2, the VE/VCO2 slope, and EOB to wetermine the optimal prognostic threshold value (highest
ombination of sensitivity/specificity) for overall, arrhyth-
ia, and nonarrhythmia related death. Univariate Cox
egression analysis assessed the ability of peak VO2, the
E/VCO2 slope, and EOB along with LVEF, LVESV,
nd LV mass to predict overall cardiac mortality as well as
rrhythmia (nonarrhythmia-related death treated as cen-
ored cases) and nonarrhythmia (arrhythmia related death
reated as censored cases) related death. Threshold values
etermined by ROC curve analysis for peak VO2 and the
E/VCO2 slope were used in the Cox regression analyses.
he forward stepwise method was used for the multivariate
nalyses with entry and removal p values set at 0.05 and
.10, respectively. Kaplan Meier analysis was used to assess
ifferences in cardiac-related events with variables retained
n the multivariate Cox regression analysis. The log-rank
est was used to determine whether the difference in
vent-free survival was significant between subjects falling
nto different categories. All data are reported as mean
alues  SD. Statistical differences with a p value  0.05
ere considered significant.
esults
he mean tracking period was 23.6  18.0 months.
hirty-four subjects died from cardiac causes during the
-year tracking period. The annual mortality rate was 9.6%.
eventeen deaths were due to SCD, whereas the remaining
7 were secondary to pump failure. No patients were lost to
ollow-up. Twelve patients had ventricular fibrillation suc-
essfully terminated by the ICD. Seven patients underwent
eart transplantation.
atients’ characteristics according to clinical outcome. Pa-
ient characteristics according to the clinical outcome are
iven in Table 1. Left ventricular ejection fraction was
ignificantly lower in the SCD group compared with survi-
ors and the pump failure death group. In SCD patients
VESV, LVEF, and LV mass were significantly greater
han in survivors and in those dying because of pump failure.
New York Heart Association (NYHA) functional class
vivors (n  122)
Nonsurvivors (n  34)
SCD (n  17) Pump Failure (n  17)
16.8 4.5* 13.5 3.2 14.1 4.7
32.8 6.4† 41.5 11.4 38.1 7.3
1.00 0.12‡ 1.03 0.17 1.09 0.08
34.0 5.4* 30.4 5.0 31.1 4.5
22† 100§ 47
26† 59 65
33‡ 71 53
5). †Survivors significantly less than SCD and pump failure death group (p  0.01). ‡Survivors
up (p  0.01).
rbon dioxide; RER  respiratory exchange ratio; VE/VCO2  ventilation to CO2 production; VO2 Sur
 0.0
ath groas significantly lower in survivors compared with the SCD
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Exercise Periodic Breathing and Sudden Death July 24, 2007:299–308nd pump failure group. Lastly, there were significant
ifferences in the number of subjects receiving antialdoste-
one and beta-blocking agents amongst the 3 groups.
xercise test results are presented in Table 2. Peak VO2 was
ignificantly greater and the VE/VCO2 slope and EOB
revalence were significantly lower in survivors compared
ith the other groups. Peak RER was significantly lower in
urvivors compared with the pump failure death group.
lthough peak VO2 and the VE/VCO2 slope were not
Figure 1 ROC Curves Showing the Ability of Peak VO2 to Predict
Overall Mortality, SCD, and Pump Failure Death
For panel A overall mortality: area under the curve 0.71, p  0.001, 95%
confidence interval (CI) 0.61 to 0.81, optimal threshold /14.4, sensitivity
67, specificity 72. For panel B sudden cardiac death (SCD): area under the
curve 0.70, p  0.006, 95% CI 0.58 to 0.82, optimal threshold /14.4,
sensitivity 65, specificity 71. For panel C cardiac pump failure: area under
the curve 0.66, p  0.03, CI 0.51 to 0.78, optimal threshold /13, sensitiv-
ity 73, specificity 53. ROC  receiver-operating characteristic; VO2  oxygen
uptake.ignificantly different between the arrhythmia and non- rrrhythmia groups, prevalence of EOB was greater in SCD
atients (100% vs. 47.1%; p  0.01).
Receiver-operating characteristic curve analysis for each
entilatory variable according to overall mortality, SCD, and
ump failure mortality are reported in Figures 1, 2, and 3,
espectively. Results of ROC curve analysis for LV mass,
VESV, and LVEF are presented in Table 3. Peak VO2
nd the VE/VCO2 slope classification schemes were signif-
cant for all 3 scenarios. The EOB classification scheme was
ignificant for overall cardiac mortality and arrhythmia-
Figure 2 ROC Curves Showing the Ability of VE/VCO2 Slope to
Predict Overall Mortality, SCD, and Pump Failure Death
For panel A overall mortality: area under the curve 0.74, p  0.001, 95% CI
0.61 to 0.81, optimal threshold /37.0, sensitivity 75, specificity 62. For
panel B SCD: area under the curve 0.74, p  0.002, 95% CI 0.61 to 0.81,
optimal threshold /39.2, sensitivity 81, specificity 53. For panel C cardiac
pump failure: area under the curve 0.69, p  0.01, 95% CI 0.61 to 0.81, opti-
mal threshold /37.0, sensitivity 72, specificity 65. VE/VCO2  ventilation/
carbon dioxide production; other abbreviations as in Figure 1.elated mortality only. The area under the curve was greatest
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July 24, 2007:299–308 Exercise Periodic Breathing and Sudden Deathor EOB for the overall cardiac mortality and arrhythmia-
elated mortality classification schemes. The area under the
urve was greatest for the VE/VCO2 slope for nonarrhythmia-
elated mortality.
redictors of mortality. Univariate predictors of death are
eported in Table 4. At univariate analysis, all CPET
ariables of interest along with cardiac function parameters
ere significant predictors of overall cardiac mortality, SCD
ortality, and pump failure mortality. However, as to
PET variables, EOB performed somewhat better than
E/VCO2 slope and peak VO2. Analyses of the Kaplan-
Figure 3 ROC Curves Showing the Ability of EOB to Predict
Overall Mortality, SCD, and Pump Failure Death
For panel A overall mortality: area under the curve 0.78, p  0.001, 95% CI
0.61 to 0.81, optimal threshold N/A, sensitivity 78, specificity 73. For panel B
SCD: area under the curve 0.87, p  0.001, 95% CI 0.61 to 0.81, optimal
threshold N/A, sensitivity 75, specificity 100. For panel C cardiac pump failure:
area under the curve 0.58, p  0.30, 95% CI 0.61 to 0.81, optimal threshold
N/A, sensitivity 69, specificity 47. EOB  exercise oscillatory breathing; other
abbreviations as in Figure 1.eier survival curves revealed a 4-year total cardiac mortal- cty survival rate of 100% for those with no EOB compared
ith only 67.3% for those with EOB (Fig. 4). An even
orse survival rate was observed when considering SCD
ortality group (51.9%) (Fig. 5) for patients exhibiting
OB. The worse 4-year Kaplan-Meier survival rate in the
ump failure mortality group was observed for patients with
E/VCO2 slope 37 (Fig. 6).
ultivariate Cox regression analysis. Multivariate Cox
roportional hazards model analyses for different causes of
eath are reported in Table 5. The EOB was the strongest
redictor of overall and SCD mortality, whereas VE/VCO2
lope maintained a predictive value as to overall cardiac
ortality and pump failure death outperforming EOB as
redictor of pump failure mortality. Remarkably, peak VO2
id not emerge as a predictor independently of type of
ardiac death considered.
As to cardiac function, LVEF did not emerge as a
redictor of any end point; LV mass showed a high
rognostic predictivity for overall cardiac mortality, SCD,
nd pump failure death. The LVESV strongly predicted
ump failure death and not SCD.
iscussion
irect comparison among recognized prognostic CPET-
erived variables has shown EOB as the only independent
redictor of SCD. The information is novel. It expands the
ounting clinical and prognostic relevance provided by
PET and strengthens the importance of critically inter-
reting exercise ventilatory abnormalities in the follow-up
f CHF patients. In this respect, occurrence of exercise
scillatory gas exchange kinetics seems worth taking into
ccount as a potential additional marker for potential
rioritization to ICD therapy.
PET variables and prediction of mode of death. Peak
O2 is an established prognosticator in patients with advanced
HF (7) independently of beta-blocker use (8) and remains
he only noninvasive variable that represents an absolute key
ndication to list for heart transplantation (23). In recent years,
variables have been progressively attracting the interest and,
specially in patients with intermediate exercise performance,
ave proven to be superior to peak VO2: 1) the increased slope
f VE/VCO2 production (9–14); and 2) the oscillatory kinet-
cs in expired gases and ventilatory response to incremental
xercise (15,16,24). Interestingly enough, the respective pre-
ictive ability of these variables in the definition of mode of
eath has not been previously investigated, and studies per-
ormed on large patient populations have focused on the
PET variables’ prediction of overall cardiac and/or total
ortality, without providing insights into the mode of death
4–18).
In the present investigation, all CPET variables were
redictive of overall cardiac mortality, with EOB perform-
ng better than peak VO2 and VE/VCO2 slope. However,
lear differences in the predictive accuracy have emerged
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Exercise Periodic Breathing and Sudden Death July 24, 2007:299–308hen patients were grouped according to sudden or non-
udden cardiac death.
OB and SCD prediction. In CHF, EOB occurs in a
ercentage that ranges between 12% and 30%, according to
ifferent criteria used to classify oscillatory pattern and its
eatures (15,16,24). The EOB prevalence in our patient
opulation was 33% and, remarkably, it was present in all
ases of SCD.
Data provided by the landmark study by Mancini et al.
7) showed that among patients who were deferred from
eart transplantation because of a peak VO2 14
l·min1·kg1, mode of death was sudden in all cases.
onsistently, in the present study, performed in the beta-
OC Curve Results
Table 3 ROC Curve Results
ROC Area p Value
Overall cardiac mortality
LV mass, g 0.66 0.03
LVESV, ml 0.74 0.001
LVEF, % 0.49 0.92
SCD
LV mass, g 0.83 0.001
LVESV, ml 0.64 0.07
LVEF, % 0.82 0.001
Pump failure death
LV mass, g 0.66 0.03
LVESV, ml 0.74 0.001
LVEF, % 0.49 0.92
I  confidence interval; ROC  receiver-operating characteristic; other abbreviations as in Table
nivariate Cox Regression Analysis
Table 4 Univariate Cox Regression Analysis
Chi-Square Hazard Ratio 95% CI
Overall cardiac mortality
Peak VO2 9.8* 2.9* 1.4–5.8
VE/VCO2 slope 19.0† 4.1† 2.1–8.3
EOB 38.7† 7.9† 3.7–17.0
LV mass 37.3† 6.8† 3.3–13.8
LVESV 31.5† 6.1† 3.0–12.5
LVEF 8.2* 2.6* 1.3–5.3
SCD
Peak VO2 8.8* 4.3* 1.5–12.1
VE/VCO2 slope 14.9* 5.4* 2.1–14.1
EOB 39.6† 45.4† 6.0–34.3
LV mass 28.3† 11.4† 3.7–35.0
LVESV 9.3* 4.2* 1.5–11.2
LVEF 17.7† 6.9† 2.4–19.6
Pump failure death
Peak VO2 7.5‡ 3.5‡ 1.3–9.1
VE/VCO2 slope 11.8* 4.9* 1.8–13.3
EOB 4.3‡ 2.7‡ 1.0–6.9
LV mass 12.7† 4.9* 1.9–12.7
LVESV 28.1† 10.6† 3.7–30.1
LVEF 0.12 N/A N/Ag
p  0.01; †p  0.001; ‡p  0.05.
Abbreviations as in Tables 1, 2, and 3.locker era, average peak VO2 was similar to Mancini’s
opulation in both cases of SCD and pump failure deaths,
einforcing the information that SCD might occur also in
atients with a “non-prognostic” peak VO2.
Most of the recent literature highlights exercise VE/
CO2 slope as the reference prognostic marker in CHF
9–14,17,18). In the present study, VE/VCO2 slope was
ot actually predictive of SCD but emerged as the strongest
ndependent marker of cardiac pump failure events. None-
heless, a large number of patients (59%) who died of SCD
xhibited a high VE/VCO2 slope, implying that a further
ote of attention to preventive strategies and clinical
ecision-making is advisable when both abnormal ventila-
ory features are present.
The mechanisms responsible for EOB might well be
ultifactorial, but, in principle, an instability in feedback
eripheral and central chemoreflex control of ventilation can
e involved (19,25). The link between these abnormalities
nd multiple aspects of the pathophysiology of heart failure
yndrome lends support to the EOB’s remarkably superior
alue in the clinical assessment of the whole spectrum of
HF patients (15,16,24) and to its special meaning in
redicting SCD. Specifically, an impaired chemosensitivity,
hich might even occur in the early stages of heart failure
isease or in the presence of a quite preserved exercise
erformance, is related to severe autonomic imbalance with
ncreased sympathetic activation (26,27) and high preva-
ence of ventricular arrhythmias (28,29) and is, per se, an
ndependent prognostic marker (18). It is tempting to
peculate on the potential reasons whereby, despite similar
nd interdependent pathways that are postulated to be
ommon in both increased VE/VCO2 slope and EOB (19),
he latter emerges as the reference CPET predictor of SCD.
As recently demonstrated by other authors (24), EOB is
ssociated in a very high percentage of cases with sleep-
isordered breathing, namely with sleep apnea of central
rigin. This important association might suggest that EOB
s a clinical manifestation whose pathophysiological back-
95% CI Optimal Threshold Sensitivity/Specificity
.50–0.82 /238.0 77/53
.62–0.86 /112.0 74/65
.32–0.66 N/A N/A
.73–0.92 /232.0 77/76
.49–0.79 /117.0 74/47
.73–0.91 /29.0 82/71
.50–0.82 /238.0 77/53
.62–0.86 /112.0 74/65
.32–0.66 N/A N/A0
0
0
0
0
0
0
0
0round recognizes a more severe state of demodulated
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ccordingly, it might be hypothesized that patients with
OB are those in whom chemoreflex overactivity, activation
f sympathetic nervous system, and baroreflex impairment
re more pronounced, making patients more vulnerable to
he occurrence of arrhythmic events. These speculations
ight be supported or denied by trials specifically designed
Figure 4 Overall Cardiac Mortality Kaplan-Meier Plots Relating
Abbreviations as in Figures 1, 2, and 3.
Figure 5 SCD Mortality Kaplan-Meier Plots Relating Survival to
Abbreviations as in Figures 1, 2, and 3.o identify autonomic and ventilatory control differences in
arge subgroups of CHF patients with or without EOB,
hose breathing pattern is also investigated during sleep.
Furthermore, the relevance of EOB in discriminating
CD risk will be reinforced by studies in CHF populations
overing a wide demographic spectrum and a variable range
f severity of LV systolic and diastolic dysfunction.
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umber of events limited the number of variables in our
egression model. However, the study was aimed at making
head-to-head comparison among established CPET-
erived variables.
Our reported associations were adjusted for known prog-
ostic factors, but we were unable to adjust our findings for
ther important prognostic indicators, including biomarkers
f neurohumoral activation and neural predictors of SCD.
urthermore, despite a similar cardiopulmonary perfor-
ance in SCD patients, as in the pump failure group—as
eflected by average peak VO2, peak RER, and VE/VCO2
lope—LVEF was significantly lower (25% vs. 35%; p 
.05) and LVESV and LV mass were significantly greater in
CD. In this regard, at multivariate analysis, LV mass
howed a high prognostic predictivity for overall cardiac
ortality and, consistent with findings from Framingham
tudy, for SCD (30). The LVESV strongly predicted pump
ailure death and not SCD.
However, owing to the relatively limited number of
eaths, we could not perform a specific EOB stratification
y including LVEF and LV mass. Further work in a larger
tudy cohort is warranted to determine whether EOB is
ndependently associated with mortality after adjustment for
hese other known prognostic markers. Additional data on
he eventual association between EOB and hospital stays for
HF are also needed. The SCD patients were receiving
eta-blocker therapy in a lower percentage of cases com-
ared with survivors and pump failure patients. This was
ue to the greater number of cases in NYHA functional
Figure 6 Pump Failure Mortality Kaplan-Meier Plots Relating S
Abbreviations as in Figures 1, 2, and 3.lass IV, who were intolerant to even lower drug titration aoses. Nonetheless, in a quite high rate of cases, SCD
atients were receiving spironolactone, a drug whose anti-
ailure benefits might well translate into an antiarrhythmic
ffect and prevention of SCD (31). Another main point that
eeds critical and cautious evaluation is the theoretical
mplication of using EOB as a marker for prioritization to
CD implantation. In fact, reasoning on our numbers only,
ne-third of patients would get benefit from ICD on the
asis of an EOB diagnosis. Specifically, at 2 years’ follow-up
or every 100 HF patients, 78 will survive and 22 will die
rom pump failure or SCD. Among survivors, 17 will have
OB. Because the number of SCD is only 11% of the total,
ven though all were associated with EOB, it amounts to an
bsolute number of 11 patients/100 with HF. Also, by the
ame calculation, 11 pump failure deaths/100 CHF patients
ould be expected and 47% (5) will have EOB. Thus, the
otal number of patients with EOB (per 100 CHF patients)
omes to 33; however, only 11 among the whole EOB
opulation would eventually get benefit from the device. On
he basis of these considerations, proposal of ICD implan-
ation simply on this particular data set does not seem
dvisable. This, of course, points out the complexity of
he problem, which involves ethical as well as financial
ssues, problems that are well behind the scope of this
nvestigation.
onclusions
xercise oscillatory breathing has emerged as a possibly
ndependent predictor of SCD in patients with CHF as well
l to EOB, VE/VCO2 Slope, and Peak VO2urvivas a promising additional marker for determining which
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nd eventually ICD implantation. To confirm and expand
hese findings, additional trials in large CHF populations
re needed.
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